Wild type measles virus attenuation independent of type I IFN

Virology Journal

Volumn 5, Issue , 2008, Pages

  Druelle, Johan ^a,b,c   Sellin, Caroline I ^a,b,c   Waku Kouomou, Diane ^a,b,c,d   Horvat, Branka ^a,b,c   Wild, Fabian T ^a,b,c,d  

^a INSERM   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d Ctr Natl de Ref pour la Grippe   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; HYBRID PROTEIN; INTERFERON; MATRIX PROTEIN; VIRUS ANTIBODY;

ARTICLE; CELL TYPE; CONTROLLED STUDY; DENDRITIC CELL; GENE MUTATION; GENOME; HUMAN; HUMAN CELL; MEASLES VIRUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; SEQUENCE ANALYSIS; VERO CELL; VIRUS INFECTION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS STRAIN; AMINO ACID SEQUENCE; ANIMAL; BLOOD; C57BL MOUSE; CELL LINE; CERCOPITHECUS; DNA SEQUENCE; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MEASLES; METHODOLOGY; MOLECULAR GENETICS; MUTATION; PATHOGENICITY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; VIROLOGY; VIRUS CULTURE; VIRUS GENE;

MEASLES VIRUS; PRIMATES;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; CELL LINE; CERCOPITHECUS AETHIOPS; GENES, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON TYPE I; MEASLES; MEASLES VIRUS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SERIAL PASSAGE; VERO CELLS; VIRUS REPLICATION;

EID: 42449147950     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-5-22     Document Type: Article

References (43)

1. Measles Virus. In Fields Virology 5th edition. DE Griffin, D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, and S.E. Straus, Eds 2006 1551 1585
2. SLAM (CDw150) is a cellular receptor for measles virus. H Tatsuo N Ono K Tanaka Y Yanagi, Nature 2000 406 6798 893 897 10.1038/35022579 10972291
3. The human CD46 molecule is a receptor for measles virus (Edmonston strain). RE Dörig A Marcil A Chopra CD Richardson, Cell 1993 75 295 305 10.1016/0092-8674(93)80071-L 8402913
4. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. D Naniche G Varior-Krishnan F Cervoni TF Wild B Rossi C Rabourdin-Combe D Gerlier, J Virol 1993 67 10 6025 6032 8371352
5. Interaction of measles virus (Halle strain) with CD46: evidence that a common binding site on CD46 facilitates both CD46 downregulation and MV infection. V Lecouturier A Rizzitelli J Fayolle L Daviet FT Wild R Buckland, Biochem Biophys Res Commun 1999 264 1 268 275 10.1006/bbrc.1999.1517 10527876
6. Identification of a second major site for CD46 binding in the hemagglutinin protein from a laboratory strain of measles virus (MV): potential consequences for wild-type MV infection. N Masse T Barrett CP Muller TF Wild R Buckland, J Virol 2002 76 24 13034 13038 12438629 10.1128/JVI.76.24.13034-13038. 2002
7. Distinct kinetics for binding of the CD46 and SLAM receptors to overlapping sites in the measles virus hemagglutinin protein. C Santiago E Bjorling T Stehle JM Casasnovas, J Biol Chem 2002 277 35 32294 32301 10.1074/jbc.M202973200 12065582
8. SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. K Hashimoto N Ono H Tatsuo H Minagawa M Takeda K Takeuchi Y Yanagi, J Virol 2002 76 13 6743 6749 12050387 10.1128/JVI.76.13.6743-6749.2002
9. Studies towards the identification and characterization of a third receptor for measles virus on human and marmoset smooth airway epithelial cells: June 17th - 22nd 2006; Salamanca, Spain. CD Richardson Sarangi, F., Iorio, C., 2006
10. Adaptation of wild-type measles virus to tissue culture. DW Kouomou TF Wild, J Virol 2002 76 3 1505 1509 11773423
11. Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production. D Naniche A Yeh D Eto M Manchester RM Friedman MB Oldstone, J Virol 2000 74 16 7478 7484 10906201 10.1128/JVI.74.16.7478-7484.2000
12. Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus. Y Nakatsu M Takeda S Ohno R Koga Y Yanagi, J Virol 2006 80 23 11861 11867 16987969 10.1128/JVI.00751-06
13. STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. H Palosaari JP Parisien JJ Rodriguez CM Ulane CM Horvath, J Virol 2003 77 13 7635 7644 12805463 10.1128/JVI.77.13.7635-7644.2003
14. The C protein of measles virus inhibits the type I interferon response. JA Shaffer WJ Bellini PA Rota, Virology 2003 315 2 389 397 10.1016/S0042- 6822(03)00537-3 14585342
15. Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. S Ohno N Ono M Takeda K Takeuchi Y Yanagi, J Gen Virol 2004 85 Pt 10 2991 2999 10.1099/vir.0.80308-0 15448362
16. Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation. K Takeuchi SI Kadota M Takeda N Miyajima K Nagata, FEBS Lett 2003 545 2-3 177 182 10.1016/S0014-5793(03)00528-3 12804771
17. Growth arrest of epithelial cells during measles virus infection is caused by upregulation of interferon regulatory factor 1. S Yokota T Okabayashi N Yokosawa N Fujii, J Virol 2004 78 9 4591 4598 15078941 10.1128/JVI.78.9.4591- 4598.2004
18. The nature of the principal type 1 interferon-producing cells in human blood. FP Siegal N Kadowaki M Shodell PA Fitzgerald-Bocarsly K Shah S Ho S Antonenko YJ Liu, Science 1999 284 5421 1835 1837 10.1126/science.284.5421.1835 10364556
19. Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J Schlender V Hornung S Finke M Gunthner-Biller S Marozin K Brzozka S Moghim S Endres G Hartmann KK Conzelmann, J Virol 2005 79 9 5507 5515 15827165 10.1128/JVI.79.9.5507-5515.2005
20. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. F Kobune H Sakata A Sugiura, J Virol 1990 64 2 700 705 2153236
21. Nonhuman primate models of measles. F Kobune H Takahashi K Terao T Ohkawa Y Ami Y Suzaki N Nagata H Sakata K Yanamouchi C Kai, Laboratory Animal Science 1996 46 3 315 320 8799939
22. Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. M Takeda A Kato F Kobune H Sakata Y Li T Shioda Y Sakai M Asakawa Y Nagai, J Virol 1998 72 11 8690 8696 9765410
23. Comparative nucleotide sequence analyses of the entire genomes of B95a cell-isolated and vero cell-isolated measles viruses from the same patient. K Takeuchi N Miyajima F Kobune M Tashiro, Virus Genes 2000 20 3 253 257 10.1023/A:1008196729676 10949953
24. Contributions of matrix and large protein genes of the measles virus edmonston strain to growth in cultured cells as revealed by recombinant viruses. M Tahara M Takeda Y Yanagi, J Virol 2005 79 24 15218 15225 16306593 10.1128/JVI.79.24.15218-15225.2005
25. Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion. M Tahara M Takeda Y Yanagi, J Virol 2007 81 13 6827 6836 17442724 10.1128/JVI.00248-07
26. High pathogenicity of wild-type measles virus infection in CD150 (SLAM) transgenic mice. CI Sellin N Davoust V Guillaume D Baas MF Belin R Buckland TF Wild B Horvat, J Virol 2006 80 13 6420 6429 16775330 10.1128/JVI.00209-06
27. Functional role of type I and type II interferons in antiviral defense. U Muller U Steinhoff LF Reis S Hemmi J Pavlovic RM Zinkernagel M Aguet, Science 1994 264 5167 1918 1921 10.1126/science.8009221 8009221
28. A new mathematical model for relative quantification in real-time RT-PCR. MW Pfaffl, Nucleic Acids Res 2001 29 9 e45 11328886 10.1093/nar/29.9.e45
29. The plasmacytoid monocyte/interferon producing cells. F Facchetti W Vermi D Mason M Colonna, Virchows Arch 2003 443 6 703 717 10.1007/s00428-003-0918-8 14586652
30. Passage in Vero cells alters the characteristics of measles AIK-C vaccine strain. H Uejima T Nakayama K Komase, Vaccine 2006 24 7 931 936 10.1016/j.vaccine.2005.08.082 16176848
31. Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage. CL Parks RA Lerch P Walpita HP Wang MS Sidhu SA Udem, J Virol 2001 75 2 910 920 11134304 10.1128/JVI.75.2.910-920.2001
32. Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-alpha/beta signaling. G Caignard M Guerbois JL Labernardiere Y Jacob LM Jones F Wild F Tangy PO Vidalain, Virology 2007 17686504
33. Differential Type I IFN-Inducing Abilities of Wild-Type versus Vaccine Strains of Measles Virus. M Shingai T Ebihara NA Begum A Kato T Honma K Matsumoto H Saito H Ogura M Matsumoto T Seya, J Immunol 2007 179 9 6123 6133 17947687
34. Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells. C Escoffier S Manie S Vincent CP Muller M Billeter D Gerlier, J Virol 1999 73 2 1695 1698 9882382
35. Role of V protein RNA binding in inhibition of measles virus minigenome replication. CL Parks SE Witko C Kotash SL Lin MS Sidhu SA Udem, Virology 2006 348 1 96 106 10.1016/j.virol.2005.12.018 16442140
36. Mutations in the measles virus C protein that up regulate viral RNA synthesis. GL Reutter C Cortese-Grogan J Wilson SA Moyer, Virology 2001 285 1 100 109 10.1006/viro.2001.0962 11414810
37. Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. C Tober M Seufert H Schneider MA Billeter ICD Johnston S Niewiesk V ter Meulen S Schneider-Schaulies, Journal of Virology 1998 72 10 8124 8132 9733853
38. Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation. RG Paterson CJ Russell RA Lamb, Virology 2000 270 1 17 30 10.1006/viro.2000.0267 10772976
39. Recombinant meales viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. A Valsamakis H Schneider PG Auwaerter H Kaneshima MA Billeter DE Griffin, Journal of Virology 1998 72 10 7754 7761 9733811
40. Stringent requirement for the C protein of wild-type measles virus for growth both in vitro and in macaques. K Takeuchi M Takeda N Miyajima Y Ami N Nagata Y Suzaki J Shahnewaz S Kadota K Nagata, J Virol 2005 79 12 7838 7844 15919937 10.1128/JVI.79.12.7838-7844.2005
41. RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription. T Reuter B Weissbrich S Schneider-Schaulies J Schneider-Schaulies, J Virol 2006 80 12 5951 5957 16731933 10.1128/JVI.02453-05
42. Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. P Devaux V von Messling W Songsungthong C Springfeld R Cattaneo, Virology 2007 360 1 72 83 10.1016/j.virol.2006.09.049 17112561
43. Further-attenuated measles vaccine: virus passages affect viral surface protein expression, immunogenicity and histopathology pattern in vivo. OA Sinitsyna OE Khudaverdyan LL Steinberg FG Nagieva VD Lotte LV Dorofeeva EE Rozina S Boriskin Yu, Res Virol 1990 141 5 517 531 10.1016/0923-2516(90)90084-V 2277869